Cargando…
Management of Travel-Related Infectious Diseases in the Emergency Department
PURPOSE OF REVIEW: Emergency physicians generally have limited exposure to internationally acquired illnesses. However, travelers can present quite ill, and delays in recognition and treatment can lead to increased morbidity and mortality. This paper aims to summarize typical presentations of common...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200320/ https://www.ncbi.nlm.nih.gov/pubmed/32377443 http://dx.doi.org/10.1007/s40138-020-00213-6 |
_version_ | 1783529307704918016 |
---|---|
author | Throckmorton, Laura Hancher, Jonathan |
author_facet | Throckmorton, Laura Hancher, Jonathan |
author_sort | Throckmorton, Laura |
collection | PubMed |
description | PURPOSE OF REVIEW: Emergency physicians generally have limited exposure to internationally acquired illnesses. However, travelers can present quite ill, and delays in recognition and treatment can lead to increased morbidity and mortality. This paper aims to summarize typical presentations of common international diseases and provide the emergency physician with a practical approach based on current guidelines. RECENT FINDINGS: In the treatment of traveler’s diarrhea, azithromycin has become the treatment of choice due to the growing antibiotic resistance. Intravenous artesunate was approved in 2019 under investigational new drug protocol for the treatment of severe malaria, and artemisinin-based combination therapies (ACTs) have become the first-line treatment for most cases of uncomplicated malaria. Since the 2015 outbreak, Zika has become a concern to many travelers, but the current treatment is supportive. SUMMARY: Clinicians should be aware of a few noteworthy updates in the treatment of internationally acquired illnesses, but more importantly, they must recognize warning signs of severe illness and treat promptly. Future research on workup and disposition could help emergency physicians identify which patients need admission in well-appearing febrile travelers. |
format | Online Article Text |
id | pubmed-7200320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-72003202020-05-06 Management of Travel-Related Infectious Diseases in the Emergency Department Throckmorton, Laura Hancher, Jonathan Curr Emerg Hosp Med Rep Infectious Disease (J Glauser, Section Edior) PURPOSE OF REVIEW: Emergency physicians generally have limited exposure to internationally acquired illnesses. However, travelers can present quite ill, and delays in recognition and treatment can lead to increased morbidity and mortality. This paper aims to summarize typical presentations of common international diseases and provide the emergency physician with a practical approach based on current guidelines. RECENT FINDINGS: In the treatment of traveler’s diarrhea, azithromycin has become the treatment of choice due to the growing antibiotic resistance. Intravenous artesunate was approved in 2019 under investigational new drug protocol for the treatment of severe malaria, and artemisinin-based combination therapies (ACTs) have become the first-line treatment for most cases of uncomplicated malaria. Since the 2015 outbreak, Zika has become a concern to many travelers, but the current treatment is supportive. SUMMARY: Clinicians should be aware of a few noteworthy updates in the treatment of internationally acquired illnesses, but more importantly, they must recognize warning signs of severe illness and treat promptly. Future research on workup and disposition could help emergency physicians identify which patients need admission in well-appearing febrile travelers. Springer US 2020-05-06 2020 /pmc/articles/PMC7200320/ /pubmed/32377443 http://dx.doi.org/10.1007/s40138-020-00213-6 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Infectious Disease (J Glauser, Section Edior) Throckmorton, Laura Hancher, Jonathan Management of Travel-Related Infectious Diseases in the Emergency Department |
title | Management of Travel-Related Infectious Diseases in the Emergency Department |
title_full | Management of Travel-Related Infectious Diseases in the Emergency Department |
title_fullStr | Management of Travel-Related Infectious Diseases in the Emergency Department |
title_full_unstemmed | Management of Travel-Related Infectious Diseases in the Emergency Department |
title_short | Management of Travel-Related Infectious Diseases in the Emergency Department |
title_sort | management of travel-related infectious diseases in the emergency department |
topic | Infectious Disease (J Glauser, Section Edior) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200320/ https://www.ncbi.nlm.nih.gov/pubmed/32377443 http://dx.doi.org/10.1007/s40138-020-00213-6 |
work_keys_str_mv | AT throckmortonlaura managementoftravelrelatedinfectiousdiseasesintheemergencydepartment AT hancherjonathan managementoftravelrelatedinfectiousdiseasesintheemergencydepartment |